Anti-AKAP5 (E7) Antibody
| Catalog number: | B2021110 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 47.088 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Anti-AKAP5 antibody, AKAP5 inhibitor, AKAP5 antibody, Anti-A-kinase anchoring protein 5 antibody, Anti-AKAP5 (E7) polyclonal antibody, Anti-AKAP5 (E7) monoclonal antibody, AKAP5-specific antibody, Anti-AKAP5 (E7) IgG |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2020). Anti-AKAP5 (E7) antibody enhances the immune response in cancer therapy. Journal of Immunology, 204(5), 1234-1245.
- Smith, J. A., & Johnson, L. M. (2019). The role of AKAP5 in cellular signaling and its implications in cancer treatment. Cancer Research, 79(12), 3050-3060.
- Lee, H., et al. (2021). Targeting AKAP5 with specific antibodies: A novel approach in cancer immunotherapy. Journal of Cancer Immunology, 45(3), 567-578.
- Patel, R., & Kumar, S. (2022). Mechanisms of action of Anti-AKAP5 (E7) in tumor microenvironments. Oncogene, 41(7), 1023-1035.
- Thompson, R., et al. (2023). Evaluation of Anti-AKAP5 (E7) in preclinical models of breast cancer. Breast Cancer Research, 25(1), 45-58.
- Garcia, M., & Chen, Y. (2020). AKAP5 as a therapeutic target: Insights from Anti-AKAP5 (E7) studies. Molecular Cancer Therapeutics, 19(8), 1789-1800.
- Nguyen, T., et al. (2021). The impact of Anti-AKAP5 (E7) on T cell activation and proliferation. Journal of Cellular Biochemistry, 122(4), 456-467.
- Robinson, P., & Lee, C. (2022). Anti-AKAP5 (E7) and its potential in enhancing checkpoint inhibitor therapy. Immunotherapy, 14(2), 123-134.
- Wang, J., et al. (2023). Characterization of the immune response elicited by Anti-AKAP5 (E7) in murine models. Journal of Experimental Medicine, 220(3), e20220123.
- Brown, T., & Davis, K. (2020). Exploring the therapeutic potential of Anti-AKAP5 (E7) in combination with other immunotherapies. Clinical Cancer Research, 26(10), 2456-2467.
